GeneDx Holdings Corp. WGS
69.60 USD +0.96 (+1.40%)
Nov 4, 2026, 2:36 PM EST
67.40 Day range 71.11
32.21 52-week range 170.87
- YTD
- -46.49%
- 1 year
- -50.10%
Financial health
Altman Z-Score
1.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -178×
FY 2019 5y median -2.0× FY 2025
P/S 8.2×
FY 2019 5y median 2.3× FY 2025
P/B 11.3×
FY 2019 5y median 1.2× FY 2025
P/FCF 245×
FY 2019 5y median -0.4× FY 2025
EV/EBITDA 535×
FY 2019 5y median -0.5× FY 2025
EV/Sales 8.3×
FY 2019 5y median 0.5× FY 2025
FCF Yield 0.4%
FY 2019 5y median -43.8% FY 2025
Profitability
Gross Margin 69.7%
FY 2019 5y median 44.4% FY 2025
Operating Margin -2.8%
FY 2019 5y median -89.2% FY 2025
Net Margin -4.9%
FY 2019 5y median -86.8% FY 2025
ROE -6.8%
FY 2019 5y median -63.2% FY 2025
ROIC -2.5%
FY 2019 5y median -49.3% FY 2025
ROA -3.7%
FY 2019 5y median -42.0% FY 2025
Growth (YoY)
Revenue 40.0%
FY 2019 FY 2025
Operating Income 49.2%
FY 2019 FY 2025
EPS (diluted) 62.4%
FY 2019 FY 2025
Free Cash Flow 142.0%
FY 2019 FY 2025
Financial Health
Current Ratio 2.5×
FY 2019 5y median 3.1× FY 2025
Quick Ratio 2.3×
FY 2019 5y median 3.0× FY 2025
Debt / Equity 0.5×
FY 2019 5y median 0.5× FY 2025
Net Debt / EBITDA 7.1×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -4.6×
FY 2019 5y median -7.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31